New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research

This funding opportunity is meant to support and encourage diverse Early Stage Investigators and New Investigators, especially those who are underrepresented in the health-related sciences.

MAXIMUM AWARD AMOUNT

$500,000 per year

OPEN TO

HEIs, Non-profits, For profit Organizations, Governments, and more.

PERIOD OF PERFORMANCE

5 years

APPLICATION DUE

Letter of intent: 30 days prior to application due date
Application: February 22, 2022 at 5:00 PM local time; February 22, 2023 at 5:00 PM local time; February 22, 2024 at 5:00 PM local time.

EXPECTED NOTIFICATION DATE

August or October

PROJECT START DATE

September to December

For more information, visit the grant page.

Defense Health Program – Department of Defense Peer Reviewed Medical Research Program Funding Opportunities for Fiscal Year 2020 (FY20)

The FY20 Defense Appropriations Act provides funding to the Department of Defense Peer Reviewed Medical Research Program (PRMRP) to support to support medical research projects of clear scientific merit and direct relevance to military health. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY20 PRMRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.   

The vision and mission of the PRMRP is improve the health, care, and well-being of all military Service members, Veterans, and beneficiaries by encouraging, identifying, selecting, and managing medical research projects of clear scientific merit and direct relevance to military health.

Congressionally Directed Topic Areas: All applications submitted to the PRMRP must address at least one of the FY20 PRMRP Congressionally directed topic areas. The FY20 PRMRP Topic Areas are as follows:

Arthritis Burn Pit Exposure
Chronic Migraine Post-Traumatic Headache
Congestive Heart Disease Diabetes
Dystonia Eating Disorder
Emerging Viral Disease Endometriosis
Epidermolysia Bullosa Familial Hypercholesterolemia
Fibrous Dysplasia Focal Segmental Glomerulosclerosis
Food Allergies Fragile X
Frontotemporal Degeneration Hepatitis B
Guillain-Barre Syndromemorrhage Control Immunomonitoring of Intestinal Transplants
Hydrocephalus Inflammatory Bowel Diseases
Interstitial Cystitis Metals Toxicology
Mitchondrial Disease Musculoskeletal Health
Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Myotonic Dystrophy Nutrition Optimization
Pancreatitis Pathogen-Inactivated Blood Products
Plant Based Vaccines Polycystic Kidney Disease
Pressure Ulcers Pulmonary Fibrosis
Resilience Training Respiratory Health
Rheumatoid Arthritis Sleep Disorders and Restriction
Spinal Muscular Atrophy Sustained Release Drug Delivery
Vascular Malformations Women’s Heart Disease

Discovery Award – Letter of Intent due April 16, 2020

Postdoctoral fellow or clinical fellow (or equivalent) and above:

  • Supports the exploration of a highly innovative new concept or untested theory.
  • Not intended to support the logical progression of an already established line of questioning.
  • Clinical trials will not be funded.
  • Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborators, and their organization(s).
  • Maximum of $200,000 for direct costs (plus indirect costs)
  • Maximum period of performance of 2 years.

Focused Program Award – Pre-proposal due April 23, 2020

Full Professor level or above (or equivalent):

  • Pre-proposal submission is required; application submission is by invitation only.
  • Supports a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal.
  • Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
  • Projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.
  • Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.
  • Maximum of $7.2 million for direct costs (plus indirect costs).
  • Maximum period of performance of 4 years.

Investigator-Initiated Research Award – Pre-proposal due April 23, 2020

Assistant Professor level or above (or equivalent):
  • Pre-proposal submission is required; application submission is by invitation only.
  • Supports research that will make an original and important contribution to the field of research or patient care in the topic area(s) of interest.
  • Partnering PI Option available.
  • Clinical trials will not be funded.
  • Maximum of $1.6 million for direct costs (plus indirect costs).
  • Maximum of $2 million for direct costs (plus indirect costs) for applications including a Partnering PI Option.
  • Maximum period of performance is 4 years.

Technology/Therapeutic Development Award – Pre-proposal due April 23, 2020

Assistant Professor level or above (or equivalent):

  • Pre-proposal submission is required; application submission is by invitation only.
  • Supports the translation of promising pre-clinical findings into clinical applications for prevention, detection, diagnosis, treatment, or quality of life.
  • Product-oriented (e.g., device, drug, clinical guidelines). The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product.
  • Clinical trials will not be funded.
  • Maximum of $4 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRMRP or other CDMRP-administered programs, please visit the CDMRP website.

Point of Contact: CDMRP Help Desk
301-682-5507
help@eBrap.org

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical Research and Development

This BAA is intended to solicit extramural research and development ideas using the authority provided by United States Code, Title 10, Section 2358. This BAA is issued under the provisions of the Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 6.102(d) (2) and 35.016 and in DoD Grant and Agreement Regulations (DoDGARs) 22.315. In accordance with FAR 6.102, projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed toward advancing the state-of-the-art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution. Research and development funding through this BAA are intended and expected to benefit and inform both military and civilian medical practice and knowledge.

This BAA provides a general description of USSOCOM’s research and development programs, including research areas of interest, evaluation and selection criteria, pre-proposal/pre-application and full proposal/application preparation instructions, and general administrative information. Submission of a pre-proposal/pre-application is required. After review, if the USSOCOM is interested in receiving a full proposal/application, the Applicant or Offeror will be invited to submit a full proposal or full application. Specific submission information and additional administrative requirements can be found in the document titled “General Submission Instructions” available in Grants.gov along with this BAA.

USSOCOM utilizes the tools and processes provided by Congressionally Directed Medical Research Programs (CDMRP). The CDMRP manages the electronic Biomedical Research Application Portal (eBRAP) system and retrieval and processing of full proposal/application submissions from Grants.gov. Refer to Section II.G, Agency Contacts, for additional information.

Notice of Special Interest (NOSI): Curriculum or Training Modules to Promote Safe and Inclusive Biomedical Research Training Environments

Notice Number: NOT-GM-20-018

Key Dates
Release Date: February 13, 2020
First Available Due Date: April 15, 2020
Expiration Date: June 01, 2020

Related Announcements: PA-18-591 “Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)”

Issued by National Institute of General Medical Sciences (NIGMS)

Purpose

The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to institutions with NIGMS training (T32, T34), certain research education (R25, see below), or institutional career development (K12) awards. The funds will support the development and implementation of curriculum or training modules to promote safe and inclusive biomedical research training environments. Applicants are strongly encouraged to discuss potential requests with their NIGMS Program Officer before submitting the supplement request.

Supplement awardees are expected to present an overview of the funded activities, the outcomes, and the progress in incorporating the activities into the ongoing program(s) at the meeting organized for Program Directors/Principal Investigators of NIGMS Training, Workforce Development, and Diversity programs.

Eligibility

Applicants must have an NIGMS-funded training (T32, T34), certain research education (R25, see below), or institutional career development (K12) program award with a project end date of May 31, 2021 or later. Awards in No-Cost Extension (NCE) are not eligible. Only R25 awards in the following programs (and associated funding opportunity announcements) are eligible for these supplements:

  • Bridges to Baccalaureate (PAR-13-333; PAR-16-110; PAR-17-210)
  • Bridges to the Doctorate (PAR-17-209; PAR-16-109)
  • Initiative for Maximizing Student Development (IMSD) (PAR-17-053; PAR-14-121)
  • Postbaccalaureate Research Education Program (PREP) (PAR-14-076; PAR-17-051)
  • Research Initiative for Scientific Enhancement (RISE) (PAR-13-196; PAR-16-118; PAR-16-361)

An applicant institution (normally identified by having a unique DUNS number or NIH Institutional Profile File – IPF) may submit only one application in this topic area. For institutions with two or more NIGMS grants, it is expected that the Program Directors/Principal Investigators will cooperate to develop curricula and/or activities that are broadly applicable to individuals at their institution and that a single supplement request will be submitted through one of the eligible NIGMS awards.

Application and Submission Information

Applications for this initiative must be submitted using the following funding opportunity announcement or its subsequent reissued equivalent.

  • PA-18-591 – Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-18-591 must be followed, with the following additions:

  • Application Due Date(s) – April 15, 2020 by 5:00 PM local time of applicant organization.
  • For funding consideration, applicants must include the term “NOT-GM-20-018” (without quotation marks) in the Agency Routing Identifier field (box 4b) of the SF424 R&R form. Applications without this information in box 4b will not be considered for this initiative.
  • NIGMS requires applicants to submit electronically through Grants.gov. The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.

Budget

  • Application budgets are limited to $80,000 direct costs and must reflect the actual needs of the proposed project.
  • Funds from this supplement may be used for salary support of individuals designing, directing, and implementing the proposed training activity. Funds may also be used for administrative staff salaries, consultant costs, equipment, research supplies, faculty/staff travel, and other expenses directly related to the proposed curricular or training activity.
  • Funds from this supplement must be expended within 12 months of the supplement award issue date.
  • Applicants should note that the funds from this supplement cannot be used to support trainee stipends or tuition (T32 or T34), participant costs (R25), or scholar costs (K12).

Research Training Program Plan (limited to 3 pages). In the Program Plan attachment, include the summary or abstract of the funded parent award(s), and describe the following:

  • The need for the proposed curricular or training activities. Describe how the activities will synergize with, but not duplicate, ongoing efforts in this area.
  • A description of the curricular or training activities and their potential impact on the biomedical training at the institution.
  • How the effectiveness of the curricular or training activities will be assessed.
  • If proven to be effective, how the curricular or training activities will be incorporated into the existing biomedical training program(s).
  • Plans for disseminating the activities and outcomes.
  • Institutional commitment for sustainability of the proposed activities

Application Review Information

NIGMS staff will consider whether the budget is fully justified and will evaluate applications using the following criteria:

  • Will the administrative supplement increase or preserve the likelihood for the program to exert a sustained, powerful influence on research training at the institution?
  • Is there a clearly identified need for the proposed curricular or training activities?
  • Are the plans to assess the outcomes likely to provide evidence of the effectiveness of the training or curricular activity?
  • Is there a plan to incorporate the activities into the ongoing conduct of the training programs?
  • Are the plans to disseminate the activities and outcomes feasible and likely to reach the intended audience?
  • Is there appropriate institutional commitment for sustaining the proposed activities?

Notice of Special Interest (NOSI): Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments

Notice Number: NOT-GM-20-016

Key Dates
Release Date: February 13, 2020
First Available Due Date: April 15, 2020
Expiration Date: June 01, 2020 Related Announcements
 PA-18-591 “Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)”

Issued by National Institute of General Medical Sciences (NIGMS)

Purpose

The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to institutions with NIGMS training (T32, T34), certain research education (R25, see below), or institutional career development (K12) awards. The funds will support the development and implementation of curricular or training activities to provide trainees and participating faculty with the knowledge and skills to enhance laboratory safety and to promote a culture of safety in the training environment. Applicants are strongly encouraged to discuss potential requests with their NIGMS Program Director before submitting the supplement request.

Supplement awardees are expected to present an overview of the funded activities, the outcomes, and the progress in incorporating the activities into the ongoing program(s) at the meeting organized for Program Directors/Principal Investigators of NIGMS Training, Workforce Development, and Diversity programs.

Eligibility

Applicants must have an NIGMS-funded training (T32, T34), certain research education (R25, see below), or institutional career development (K12) program award with a project end date of May 31, 2021 or later. Awards in No-Cost Extension (NCE) are not eligible. Only R25 awards in the following programs (and associated funding opportunity announcements) are eligible for these supplements:

  • Bridges to Baccalaureate (PAR-13-333; PAR-16-110; PAR-17-210)
  • Bridges to the Doctorate (PAR-17-209; PAR-16-109)
  • Initiative for Maximizing Student Development (IMSD) (PAR-17-053; PAR-14-121)
  • Postbaccalaureate Research Education Program (PREP) (PAR-14-076; PAR-17-051)
  • Research Initiative for Scientific Enhancement (RISE) (PAR-13-196; PAR-16-118; PAR-16-361)

An applicant institution (normally identified by having a unique DUNS number or NIH Institutional Profile File – IPF) may submit only one application in this topic area. For institutions with two or more NIGMS grants, it is expected that the Program Directors/Principal Investigators will cooperate to develop curricula and/or activities that are broadly applicable to individuals at their institution and that a single supplement request will be submitted through one of the eligible NIGMS awards. Institutions that received a previous award for the development and implementation of curricular or training activities to enhance laboratory safety through PA-18-758 are not eligible.

Application and Submission Information

Applications for this initiative must be submitted using the following funding opportunity announcement or its subsequent reissued equivalent.

  • PA-18-591 – Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-18-591 must be followed, with the following additions:

  • Application Due Date(s) – April 15, 2020 by 5:00 PM local time of applicant organization.
  • For funding consideration, applicants must include the term “NOT-GM-20-016” (without quotation marks) in the Agency Routing Identifier field (box 4b) of the SF424 R&R form. Applications without this information in box 4b will not be considered for this initiative.
  • NIGMS requires applicants to submit electronically through Grants.gov. The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.

Budget

  • Application budgets are limited to $80,000 direct costs and must reflect the actual needs of the proposed project.
  • Funds from this supplement may be used for salary support of individuals designing, directing, and implementing the proposed training activity. Funds may also be used for administrative staff salaries, consultant costs, equipment, research supplies, faculty/staff travel, and other expenses directly related to the proposed curricular or training activity.
  • Funds from this supplement must be expended within12 months of the supplement award issue date. Applicants should note that the funds from this supplement cannot be used to support trainee stipends or tuition (T34 or T32) or participant costs (R25) or scholar costs (K12).

Research Training Program Plan (limited to 3 pages). In the Program Plan attachment, include the summary or abstract of the funded parent award(s), and describe the following:

  • The need for the proposed curricular or training activities. Describe how the activities will synergize with, but not duplicate, ongoing efforts in this area.
  • A description of the curricular or training activities and their potential impact on the biomedical training at the institution.
  • How the effectiveness of the curricular or training activities will be assessed.
  • If proven to be effective, how the curricular or training activities will be incorporated into the existing biomedical training program(s).
  • Plans for disseminating the activities and outcomes.
  • Institutional commitment for sustainability of the proposed activities.

NIGMS staff will consider whether the budget is fully justified and will evaluate applications using the following criteria:

  • Will the administrative supplement increase or preserve the likelihood for the program to exert a sustained, powerful influence on research training at the institution?
  • Is there a clearly identified need for the proposed curricular or training activities?
  • Are the plans to assess the outcomes likely to provide evidence of the effectiveness of the training or curricular activity?
  • Is there a plan to incorporate the activities into the ongoing conduct of the training programs?
  • Are the plans to disseminate the activities and outcomes feasible and likely to reach the intended audience?
  • Is there appropriate institutional commitment for sustaining the proposed activities?